Arbuckle Stuart A
- SEC CIK
- 0001557290
No open-market purchases or sales filed in the past year.
Current role at each company
- RYTM Rhythm Pharmaceuticals, Inc.Directoras of Jun 25, 2026
- PRAX Praxis Precision Medicines, Inc.Directoras of Jun 12, 2026
- ALNY Alnylam Pharmaceuticals, Inc.Directoras of May 22, 2026
- VRTX Vertex Pharmaceuticals IncEVP, COOas of Jul 2, 2025
- IMGN ImmunoGen, Inc.Directoras of Feb 12, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Arbuckle Stuart A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRTX Vertex Pharmaceuticals Inc
EVP, COO19 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 (view filing) | May 15 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −69 | $430.93 | −$29.7K | −0.1%49.7K after | 10b5-1 |
| Feb 27, 2024 (view filing) | Feb 26 | 1 day | Arbuckle Stuart AEVP, COO | SSale | −5.03K | $425.70 | −$2.14M | −9.2%49.7K after | 10b5-1 |
| Feb 23, 2024 (view filing) | Feb 21 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −3.60K | $421.77 | −$1.52M | −5.7%59.4K after | 10b5-1 |
| Feb 21, 2024 (view filing) | Feb 20 | 1 day | Arbuckle Stuart AEVP, COO | SSale | −4.80K | $420.79 | −$2.02M | −7.1%63.0K after | 10b5-1 |
| Feb 13, 2024 (view filing) | Feb 12 | 1 day | Arbuckle Stuart AEVP, COO | SSale | −4.29K | $420.24 | −$1.80M | −5.4%75.7K after | 10b5-1 |
| Dec 15, 2023 (view filing) | Dec 13 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −8.60K | $399.00 | −$3.43M | −13.2%56.6K after | 10b5-1 |
| Jun 20, 2023 (view filing) | Jun 15 | 5 days | Arbuckle Stuart AEVP, COO | SSale | −8.60K | $349.00 | −$3.00M | −13.2%56.6K after | 10b5-1 |
| Jun 1, 2023 (view filing) | May 30 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −82 | $329.82 | −$27.0K | −0.1%56.6K after | 10b5-1 |
| Feb 28, 2023 (view filing) | Feb 27 | 1 day | Arbuckle Stuart AEVP, COO | SSale | −5.03K | $287.47 | −$1.45M | −8.2%56.6K after | 3 lots |
| Feb 24, 2023 (view filing) | Feb 22 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −2.40K | $294.33 | −$706.7K | −3.5%66.3K after | 5 lots |